
COVID-19 Germany local incidence and ICU occupancy (in German)
- Dashboard Heroku App - Twitter bot @corona7tage All data is based on the official APIs by RKI dashboard and DIVI

- Dashboard Heroku App - Twitter bot @corona7tage All data is based on the official APIs by RKI dashboard and DIVI

This notebook describes my approach to the Kaggle competition named in the title. This was a research competition at Kaggle in cooperation with the Memorial Sloan Kettering Cancer Center (MSKCC). The goal of the competition was to create a machine learning algorithm that can classify genetic variations that are present in cancer cells. Tumors contain cells with many different abnormal mutations in their DNA: some of these mutations are the drivers of tumor growth, whereas others are neutral and considered passengers. Normally, mutations are manually classified into different categories after literature review by clinicians. The dataset made available for this competition contains mutations that have been manually anotated into 9 different categories. The goal is to predict the correct category of mutations in the test set. ...

Health care systems world-wide are under pressure due to the high costs associated with disease. Now more than ever, particularly in developed countries, we have access to the latest advancements in medicine. This contrasts with the challenge of making those treatments available to as many patients as possible. It is imperative to find ways maximize the positive impact on the quality of life of patients, while maintaining a sustainable health care system. For this purpose I performed an analysis of Medicare data in the USA. Furthermore I used a drug-disease open database to cluster the costs by disease. I identified the most expensive diseases (mostly chronic diseases such as Diabetes) and the most expensive medicines. A drug for the treatment of HCV infections (Harvoni) stands out with the highest total costs in 2015. After this first exploration, I propose the in-depth analysis of further data to enable more targeted conclusions and recommendations to improve health care, such as linking of price databases to compare drug costs for the similar indications or the analysis of population data registers that document life style characteristics of healthy and sick individuals to identify those at risk of developing high-cost diseases. ...